Valuation: Healius Limited

Capitalization 548M 359M 307M 286M 267M 491M 30.78B 3.47B 1.31B 14.44B 1.35B 1.32B 52.87B P/E ratio 2025 *
9.45x
P/E ratio 2026 * -153x
Enterprise value 1.37B 894M 765M 712M 664M 1.22B 76.68B 8.64B 3.26B 35.96B 3.35B 3.28B 132B EV / Sales 2025 *
0.98x
EV / Sales 2026 * 1.04x
Free-Float
89.82%
Yield 2025 *
54.3%
Yield 2026 * 0.58%
More valuation ratios * Estimated data
Dynamic Chart

Last Transcript: Healius Limited

1 day+3.31%
1 week+4.70%
Current month-0.64%
1 month+0.65%
3 months-43.07%
6 months-44.88%
Current year-43.07%
More quotes
1 week 0.74
Extreme 0.735
0.78
1 month 0.7
Extreme 0.695
0.84
Current year 0.7
Extreme 0.695
1.64
1 year 0.7
Extreme 0.695
1.86
3 years 0.7
Extreme 0.695
4.08
5 years 0.7
Extreme 0.695
5.54
10 years 0.7
Extreme 0.695
5.54
More quotes
Manager TitleAgeSince
Chief Executive Officer - 2024-03-04
Director of Finance/CFO - 2024-03-04
Chief Tech/Sci/R&D Officer - 2021-03-31
Director TitleAgeSince
Director/Board Member - 2018-08-20
Chairman 66 2023-11-27
Director/Board Member - 2022-03-30
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+3.31%+4.70%-48.00%-78.92% 359M
-0.97%-8.25%+29.67%+223.88% 20.26B
+0.22%+0.89%+2.59%-20.06% 8.82B
+3.25%-0.62%-12.12%+200.26% 4.3B
-1.47%-.--% - - 3.26B
-0.11%+1.80%-0.22%+47.82% 2.91B
-1.49%-12.42%+151.00%+54.33% 2.3B
+0.34%+4.30%-0.48%-62.05% 1.88B
-0.13%+2.91%+22.60%-49.43% 1.29B
+0.39%-0.23%-18.34%-17.67% 1.26B
Average +0.44%-1.11%+14.08%+33.13% 4.66B
Weighted average by Cap. +0.26%-3.73%+20.90%+121.12%
See all sector performances

Financials

2025 *2026 *
Net sales 1.39B 909M 778M 725M 675M 1.24B 77.98B 8.79B 3.31B 36.58B 3.41B 3.34B 134B 1.41B 920M 788M 733M 683M 1.26B 78.93B 8.9B 3.35B 37.02B 3.45B 3.38B 136B
Net income 171M 112M 96.04M 89.39M 83.31M 154M 9.62B 1.08B 408M 4.51B 421M 412M 16.52B -452K -295K -253K -236K -220K -405K -25.35M -2.86M -1.08M -11.89M -1.11M -1.09M -43.55M
Net Debt 817M 535M 458M 426M 397M 732M 45.9B 5.17B 1.95B 21.53B 2.01B 1.96B 78.82B 919M 601M 515M 479M 447M 823M 51.6B 5.82B 2.19B 24.2B 2.26B 2.21B 88.62B
More financial data * Estimated data
Logo Healius Limited
Healius Limited is a healthcare company. The Company’s segments include Pathology, Imaging and Other. The Pathology segment is a provider of pathology services, including specialty pathology and clinical trials. The Imaging segment provides imaging services from standalone imaging sites, hospitals and medical centers. It has a network of pathology laboratories, collection centers and diagnostic imaging centers. It provides specialty diagnostic services to consumers and their referring practitioners. Its brands include Laverty Pathology, QML Pathology, Dorevitch Pathology, Western Diagnostic Pathology, Genomic Diagnostics, Abbott Pathology, IQ Pathology, Vetnostics, TML Vetnostics, Agilex Biolabs, Lumus Imaging, and others. Its Pathology operates 100 medical laboratories and 2,000 patient collection centers across metropolitan, regional and remote Australia. IQ Pathology is a specialized dermatopathology laboratory that provides comprehensive dermatopathology services Australia wide.
Employees
6,994
More about the company
Date Price Change Volume
25-07-17 0.7800 $ +3.31% 2,320,013
25-07-16 0.7550 $ +0.67% 2,758,181
25-07-15 0.7500 $ 0.00% 1,802,215
25-07-14 0.7500 $ -0.66% 1,206,506
25-07-11 0.7550 $ +1.34% 1,953,281

Delayed Quote Australian S.E., July 17, 2025 at 02:10 am EDT

More quotes
Trading Rating
Investor Rating
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
0.7550AUD
Average target price
1.006AUD
Spread / Average Target
+33.18%
Consensus

Quarterly revenue - Rate of surprise